4Adams WA, Mank-Senior J, Jones RS, et al. Cisatracurium in dogs with and without porto-systemic shunts[J]. Vet Anaesth Anal, 2006,33 ( 1 ) : 17.
5Sparr HJ, Beaufout TM, Fuchs-Buder T. Newer neuromuscular blocking agents:how do they compare with established agents.? [J]. Drugs,2001, 61(7):919.
6Dhonneur G, Cerf C,Lagneau F,et al.The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome[J].Anesth Analg,2001,93(2) :400.
7Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium membolite[J], gur J Anaesthesiol, 2002,19(7) :466.
8Schmith VD,Fiedler-Kelly J,Phillips L,et al. Prospective use of population pharmackinetics/pharmacodynamics in the development of cisatracurium[ J]. Phann Res, 1997,14(1 ) :91.
9Sorooshian SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and plumnacodynamics of cisatracurium in young and elderly adult patients[J].Anesthesiology, 1996,84(5) : 1083.
10Imbeault K, Withington DE, Varin F. Phaxmocokinetics and pharmacodynamics of a 0. 1mg/kg dose of cisatracurium besylate in children during N2O/O2/propofol anesthesia[ J]. Anesth Analg, 2006,102(3) : 738.
